Abstract
Bacillus Calmette Guerin (BCG) has been used to vaccinate against tuberculosis since 1921. Persistant skin and lymph node lesions yielding Mycobacterium bovis are a rare complication for which there is not standardized treatment. We report an 11 month old child with a progressive cutaneous nodule and lymphadenopathy after BCG vaccination. These rapidly cleared with administration of clarithromycin.
MeSH terms
-
Administration, Oral
-
BCG Vaccine / adverse effects*
-
BCG Vaccine / therapeutic use
-
Clarithromycin / administration & dosage
-
Clarithromycin / therapeutic use*
-
Drug Administration Schedule
-
Female
-
Humans
-
Immunocompetence*
-
Infant
-
Lymphatic Diseases / drug therapy*
-
Lymphatic Diseases / etiology
-
Lymphatic Diseases / microbiology
-
Mycobacterium bovis / immunology
-
Mycobacterium bovis / isolation & purification
-
Mycobacterium bovis / pathogenicity
-
Skin Diseases / drug therapy*
-
Skin Diseases / etiology
-
Skin Diseases / microbiology
-
Tuberculosis / prevention & control
Substances
-
BCG Vaccine
-
Clarithromycin